BBH

Investor Moves

Investor	Portfolio Value	Portfolio Change	Position Change	Avg Buy Price	Current Price
Ken GriffinCitadel Advisors $-472.7K ExitQ4 2025 $473k -- --
Ken GriffinCitadel Advisors $-472.7K ExitQ4 2025 $473k -- --
Ken GriffinCitadel Advisors $-778.1K TrimQ3 2025 $778k -- --
Ken GriffinCitadel Advisors $-778.1K TrimQ3 2025 $778k -- --
Ken GriffinCitadel Advisors $854.0K AddQ2 2025 $854k -- --
Ken GriffinCitadel Advisors $854.0K AddQ2 2025 $854k -- --

News

zacks.comInside the GLP-1 Boom: ETF Picks for the Obesity Drug Marketzacks.comJun 10

zacks.comShould You Invest in the VanEck Biotech ETF (BBH)?zacks.comMay 11

Trade BBH

About VanEck Biotech ETF

The VanEck Biotech ETF (BBH) aims to closely reflect the price appreciation and income yield of the MVIS US Listed Biotech 25 Index (MVBBHTR), prior to the deduction of fees and expenses. This index monitors the aggregate performance of corporations involved in the research, manufacturing, promotion, and sale of medications derived from genetic insights and diagnostic technologies.

IPO Date: Nov 23, 1999

Market Data

Open: $189.90
High: $189.90
Low: $185.63
Volume: 8.6K
Avg Volume: 5.1K
52W High: $202.91
52W Low: $150.18

Valuation

Market Cap: $366M
Dividend Yield: 95.7%

Financials

Financial statement snapshot is not available yet.

Events

DividendDec 22

$0.9565